• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Microbiol . Simultaneous measurement of the antibody responses against SARS-CoV-2 and its multiple variants by a phage display mediated immun

tetano

Editor, Senior Moderator
Front Microbiol


. 2022 Aug 22;13:968036.
doi: 10.3389/fmicb.2022.968036. eCollection 2022.
Simultaneous measurement of the antibody responses against SARS-CoV-2 and its multiple variants by a phage display mediated immuno-multiplex quantitative PCR-based assay


Hanyi Chen[SUP] 1 [/SUP], Shen Li[SUP] 1 [/SUP], Jiali Wang[SUP] 1 [/SUP], Siqi He[SUP] 1 [/SUP], Dong Wang[SUP] 2 [/SUP], Zhaohui Qian[SUP] 3 [/SUP], Dandan Hu[SUP] 4 [/SUP], Fangfang Qi[SUP] 5 [/SUP], Keping Hu[SUP] 6 7 [/SUP], Chenyi Luo[SUP] 1 8 [/SUP], Jianxun Wang[SUP] 1 8 [/SUP]



Affiliations

Abstract

To combat the continued pandemic of COVID-19, multiplex serological assays have been developed to comprehensively monitor the humoral immune response and help to design new vaccination protocols to different SARS-CoV-2 variants. However, multiplex beads and stably transfected cell lines require stringent production and storage conditions, and assays based on flow cytometry is time-consuming and its application is therefore restricted. Here, we describe a phage display system to distinguish the differences of immune response to antigenic domains of multiple SARS-CoV-2 variants simultaneously. Compared with linear peptides, the recombinant antigens displayed on the phage surface have shown some function that requires the correct folding to form a stable structure, and the binding efficiency between the recombinant phage and existing antibodies is reduced by mutations on antigens known to be important for antigen-antibody interaction. By using Phage display mediated immuno-multiplex quantitative PCR (Pi-mqPCR), the binding efficiency between the antibody and antigens of different SARS-CoV-2 variants can be measured in one amplification reaction. Overall, these data show that this assay is a valuable tool to evaluate the humoral response to the same antigen of different SARS-CoV-2 variants or antigens of different pathogens. Combined with high-throughput DNA sequencing technology, this phage display system can be further applied in monitoring humoral immune response in a large population before and after vaccination.

Keywords: SARS-CoV-2; antibody responses; coronavirus; phage display; variants.
 
Back
Top Bottom